Reports for GLAXOSMITHKLINE INC
Company Name
GLAXOSMITHKLINE INC
Totals |
||
Shortage reports |
322 |
|
| Actual shortage: | 10 (3%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 6 (2%) | |
| Resolved: | 306 (95%) | |
Discontinuation Reports |
56 |
|
| To be discontinued: | 2 (4%) | |
| Discontinued: | 54 (96%) | |
| Reversed: | 0 (0%) | |
Late reports |
4 (1%) |
|
Overdue reports |
0 (0%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| STIEVA-A | 0.025% | CREAM | Resolved | 2022-11-25 | 2023-02-01 | 175762 |
| EMO CORT CREAM 2.5% | 2.5% | CREAM | Resolved | 2017-03-17 | 2020-02-27 | 3254 |
| EMO CORT CREAM 2.5% | 2.5% | CREAM | Resolved | 2017-06-15 | 2020-02-27 | 12809 |
| STIEVA-A | 0.01% | CREAM | Avoided shortage | 2020-05-08 | 2020-06-12 | 114297 |
| STIEVA-A | 0.01% | CREAM | Resolved | 2021-03-12 | 2021-03-24 | 135590 |
| STIEVA-A | 0.01% | CREAM | Resolved | 2021-06-04 | 2021-07-20 | 140447 |
| STIEVA-A | 0.01% | CREAM | Resolved | 2022-01-28 | 2022-03-10 | 153792 |
| STIEVA-A | 0.01% | CREAM | Resolved | 2022-04-08 | 2022-05-18 | 158379 |
| STIEVA-A | 0.01% | CREAM | Resolved | 2022-06-24 | 2022-11-02 | 163422 |
| PREVEX B | .1% | CREAM | Resolved | 2017-03-14 | 2020-02-27 | 2734 |
| JALYN | 0.4MG 0.5MG | CAPSULE (IMMEDIATE AND EXTENDED RELEASE) | Resolved | 2018-12-12 | 2019-02-22 | 69396 |
| JALYN | 0.4MG 0.5MG | CAPSULE (IMMEDIATE AND EXTENDED RELEASE) | Resolved | 2019-05-17 | 2019-08-16 | 84337 |
| JALYN | 0.4MG 0.5MG | CAPSULE (IMMEDIATE AND EXTENDED RELEASE) | Resolved | 2020-02-21 | 2020-03-26 | 106829 |
| JALYN | 0.4MG 0.5MG | CAPSULE (IMMEDIATE AND EXTENDED RELEASE) | Resolved | 2021-11-26 | 2022-03-02 | 149987 |
| JALYN | 0.4MG 0.5MG | CAPSULE (IMMEDIATE AND EXTENDED RELEASE) | Actual shortage | 2023-11-23 | 2024-04-17 | 211335 |
| TOCTINO | 10MG | CAPSULE | Resolved | 2019-01-18 | 2019-02-05 | 72897 |
| TOCTINO | 30MG | CAPSULE | Resolved | 2021-02-19 | 2021-03-11 | 134400 |
| ZEJULA | 100MG | CAPSULE | Resolved | 2023-07-28 | 2023-09-28 | 200374 |
| ADVAIR 125 | 125MCG 25MCG | AEROSOL, METERED DOSE | Resolved | 2021-12-14 | 2022-01-19 | 151138 |
| ADVAIR 125 | 125MCG 25MCG | AEROSOL, METERED DOSE | Resolved | 2022-04-08 | 2022-05-18 | 158376 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MESASAL | 500MG | TABLET (ENTERIC-COATED) | Discontinued | 2017-03-17 | 2017-03-24 | 3333 |
| AVANDAMET | 500MG 2MG | TABLET | Discontinued | 2017-04-25 | 2017-04-26 | 8077 |
| AVANDAMET | 1000MG 2.00MG | TABLET | Discontinued | 2017-04-25 | 2017-04-26 | 8081 |
| AVANDAMET | 1000MG 4.00MG | TABLET | Discontinued | 2017-04-25 | 2017-04-26 | 8084 |
| AVANDAMET | 500MG 4MG | TABLET | Discontinued | 2017-04-25 | 2017-05-04 | 8087 |
| REQUIP | 0.25MG | TABLET | Discontinued | 2017-09-19 | 2017-11-01 | 22594 |
| REQUIP | 1MG | TABLET | Discontinued | 2017-09-19 | 2018-03-15 | 22597 |
| REQUIP | 2MG | TABLET | Discontinued | 2017-09-19 | 2018-03-15 | 22600 |
| REQUIP | 5MG | TABLET | Discontinued | 2017-09-19 | 2018-03-15 | 22603 |
| ZANTAC | 150MG | TABLET | Discontinued | 2017-09-19 | 2017-09-19 | 22611 |
| ZANTAC | 300MG | TABLET | Discontinued | 2017-09-19 | 2017-09-19 | 22614 |
| AVANDIA | 2MG | TABLET | Discontinued | 2020-04-27 | 2020-09-01 | 113311 |
| AVANDIA | 4MG | TABLET | Discontinued | 2020-04-27 | 2020-12-11 | 113314 |
| AVANDIA | 8MG | TABLET | Discontinued | 2020-04-27 | 2020-04-27 | 113317 |
| CEFTIN - TAB 250MG | 250MG | TABLET | Discontinued | 2020-07-24 | 2020-07-24 | 121046 |
| CEFTIN - TAB 500MG | 500MG | TABLET | Discontinued | 2020-07-24 | 2020-07-24 | 121049 |
| AMERGE | 1MG | TABLET | Discontinued | 2021-10-28 | 2022-08-09 | 148427 |
| AMERGE | 2.5MG | TABLET | Discontinued | 2021-10-28 | 2022-12-02 | 148430 |
| HEPTOVIR | 100MG | TABLET | Discontinued | 2022-05-13 | 2022-08-10 | 160500 |
| CLAVULIN 875 | 125MG 875MG | TABLET | Discontinued | 2024-01-18 | 2024-01-18 | 216509 |